Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member printed
title
type
uin
version
written parliamentary question type
answer	answer text
creator	label
publisher
tabling member	label

Search

1700776

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:36:23
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:45:30 22/04/2024 15:46:13
	hansard heading	Drugs: Prices
	house id	2
	identifier	HL3748
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:14:34
	question text	To ask His Majesty's Government when they will publish a timeline for the implementation of the proposed changes to Drug Tariff Part IX; provide the definition of "quality" that will be used as part of the enhanced assessment process included in those proposed changes; and publish in full the responses received to that consultation.
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3748
	type	WrittenParliamentaryQuestion
	uin	HL3748
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The consultation response on the proposed amendments to Part IX is expected to be released in May 2024, which will outline the Government’s response. Any amendments that are taken forward will happen gradually, with review points, and engagement with stakeholders, including industry, patient representatives, clinicians, and National Health Service organisations. The Department will share a timeline of the proposed changes taken forward in due course.</p><p>The Department believes that it is currently difficult to identify which devices are broadly comparable, and whether more expensive devices provide added value. The proposed amendments that were consulted on intend to increase meaningful choice, not to decrease choice for clinicians and patients. Comparison between products can increase awareness of different brands amongst prescribers, which can also support small and medium sized businesses in entering the market.</p><p>The Department is aware that there are some very good devices in use, relied upon by clinicians and patients. Part IX will remain a list of devices available to be prescribed in the community via the FP10 prescription route.</p>
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1700777

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:36:28
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:45:34 22/04/2024 15:46:11
	hansard heading	Incontinence: Drugs
	house id	2
	identifier	HL3749
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:14:34
	question text	To ask His Majesty's Government what plans they have to consult patients, clinicians and manufacturers on the categorisation of products available on Part IX of the Drug Tariff as proposed in the recent consultation paper; and what assessment they have made of the impact of the proposed changes to Drug Tariff Part IX on (1) patients with continence care needs, (2) continence care services, (3) the range of devices available to clinicians and patients, and (4) new product development and innovation in medical devices in the continence sector.
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3749
	type	WrittenParliamentaryQuestion
	uin	HL3749
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The consultation response on the proposed amendments to Part IX is expected to be released in May 2024, which will outline the Government’s response. Any amendments that are taken forward will happen gradually, with review points, and engagement with stakeholders, including industry, patient representatives, clinicians, and National Health Service organisations. The Department will share a timeline of the proposed changes taken forward in due course.</p><p>The Department believes that it is currently difficult to identify which devices are broadly comparable, and whether more expensive devices provide added value. The proposed amendments that were consulted on intend to increase meaningful choice, not to decrease choice for clinicians and patients. Comparison between products can increase awareness of different brands amongst prescribers, which can also support small and medium sized businesses in entering the market.</p><p>The Department is aware that there are some very good devices in use, relied upon by clinicians and patients. Part IX will remain a list of devices available to be prescribed in the community via the FP10 prescription route.</p>
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1700779

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:36:37
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:45:40 25/04/2024 14:47:05
	hansard heading	Suicide: Coastal Areas
	house id	2
	identifier	HL3751
	legislature	25277
	parliament number	58
	question first answered	25/04/2024 14:15:17
	question text	To ask His Majesty's Government, with reference to research by Christine Camacho and Luke Munford at the University of Manchester showing that deaths from drugs, alcohol and suicide are higher in northern and coastal local authorities, what steps they are taking to address that regional inequality.
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3751
	type	WrittenParliamentaryQuestion
	uin	HL3751
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The <em>Levelling Up the United Kingdom</em> white paper sets out the Government’s ambition to improve living standards and wellbeing across the UK, invest in communities, and improve public services. It sets mutually reinforcing levelling up missions to focus Government action, including a health mission to narrow the gap in healthy life expectancy by 2030, and increase healthy life expectancy by five years by 2035.</p><p>The Government has published a 10-year drug strategy and is investing an extra £532 million between 2022/23 to 2024/25 to improve drug and alcohol treatment and recovery services. This funding is being used by local authorities to create places for an additional 54,500 people in drug and alcohol treatment services and bolster the workforce, seeking to prevent nearly 1,000 deaths. This funding is being targeted to areas of highest need first.</p><p>The Department is increasingly focusing on supporting local areas, including better meeting the needs of vulnerable groups. Current work includes: providing targeted support to local areas; enhancing data tools to better inform local needs assessments; supporting workforce development; implementation of the commissioning quality standard; and sharing good practice. Implementation support will adapt over the course of the 10-year strategy in response to need, to ensure we reach the drug strategy goals.</p><p>We also published our new Suicide Prevention Strategy for England in September 2023, setting out the actions we will take to save lives and reduce suicides within the next few years, and have set out our intention in the strategy to write guidance for local areas to support them in aligning their own strategies with the national strategy. We have also established a £10 million Suicide Prevention Grant Fund to run from 2023 to March 2025, and on 4 March 2024 we announced the 79 organisations across the country that have been allocated funding. We have also launched a new nationwide, near real-time suspected suicide surveillance system, that will improve the early detection of, and timely action to, address changes in suicide rates or trends.</p>
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1700780

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:36:39
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:45:43 25/04/2024 14:47:08
	hansard heading	Mental Health: Equality
	house id	2
	identifier	HL3752
	legislature	25277
	parliament number	58
	question first answered	25/04/2024 14:15:17
	question text	To ask His Majesty's Government, with reference to research by Christine Camacho and Luke Munford at the University of Manchester, what steps they are taking to reduce regional inequalities in what those researchers refer to as "Deaths of Despair".
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3752
	type	WrittenParliamentaryQuestion
	uin	HL3752
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The <em>Levelling Up the United Kingdom</em> white paper sets out the Government’s ambition to improve living standards and wellbeing across the UK, invest in communities, and improve public services. It sets mutually reinforcing levelling up missions to focus Government action, including a health mission to narrow the gap in healthy life expectancy by 2030, and increase healthy life expectancy by five years by 2035.</p><p>The Government has published a 10-year drug strategy and is investing an extra £532 million between 2022/23 to 2024/25 to improve drug and alcohol treatment and recovery services. This funding is being used by local authorities to create places for an additional 54,500 people in drug and alcohol treatment services and bolster the workforce, seeking to prevent nearly 1,000 deaths. This funding is being targeted to areas of highest need first.</p><p>The Department is increasingly focusing on supporting local areas, including better meeting the needs of vulnerable groups. Current work includes: providing targeted support to local areas; enhancing data tools to better inform local needs assessments; supporting workforce development; implementation of the commissioning quality standard; and sharing good practice. Implementation support will adapt over the course of the 10-year strategy in response to need, to ensure we reach the drug strategy goals.</p><p>We also published our new Suicide Prevention Strategy for England in September 2023, setting out the actions we will take to save lives and reduce suicides within the next few years, and have set out our intention in the strategy to write guidance for local areas to support them in aligning their own strategies with the national strategy. We have also established a £10 million Suicide Prevention Grant Fund to run from 2023 to March 2025, and on 4 March 2024 we announced the 79 organisations across the country that have been allocated funding. We have also launched a new nationwide, near real-time suspected suicide surveillance system, that will improve the early detection of, and timely action to, address changes in suicide rates or trends.</p>
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1699226

	human indexable
	published
	registered interest
	answer date	11/04/2024
	date	26/03/2024
	date tabled	26/03/2024
	ddp created	26/03/2024 21:36:43
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/03/2024 21:45:25 08/04/2024 11:50:12
	hansard heading	Health Services: Procurement
	house id	2
	identifier	HL3616
	legislature	25277
	parliament number	58
	question first answered	08/04/2024 11:17:10
	question text	To ask His Majesty's Government what recent assessment they have made regarding the potential for insourcing to tackle NHS waiting lists.
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3616
	type	WrittenParliamentaryQuestion
	uin	HL3616
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Independent sector providers have a significant role to play in supporting the National Health Service as trusted partners, to recover elective services. The Elective Recovery Taskforce was launched in 2022 to consider how capacity across the system could be best utilised, including how insourcing could be used to meet the ambitions on long waits. The taskforce concluded its work by publishing an implementation plan in August 2023, which sets out a series of actions that have either been delivered, or will be delivered, over the coming months.</p><p>Local systems are best placed to consider how to utilise insourcing as part of their delivery plans, in a way which works for their areas. To support the system, NHS England produced <em>Guidance for trusts on the use of insourcing</em> and NHS Shared Business Services produced the <em>Insourcing of Clinical Services Framework Agreement</em>.</p>
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1699227

	human indexable
	published
	registered interest
	answer date	11/04/2024
	date	26/03/2024
	date tabled	26/03/2024
	ddp created	26/03/2024 21:36:44
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/03/2024 21:45:28 08/04/2024 11:50:11
	hansard heading	Health Services: Procurement
	house id	2
	identifier	HL3617
	legislature	25277
	parliament number	58
	question first answered	08/04/2024 11:17:10
	question text	To ask His Majesty's Government what steps they have taken to ensure that NHS trusts are made aware of (1) insourcing arrangements as a route to reducing local waiting lists, and (2) the benefits of insourcing for (a) patients, and (b) NHS trusts.
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3617
	type	WrittenParliamentaryQuestion
	uin	HL3617
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Independent sector providers have a significant role to play in supporting the National Health Service as trusted partners, to recover elective services. The Elective Recovery Taskforce was launched in 2022 to consider how capacity across the system could be best utilised, including how insourcing could be used to meet the ambitions on long waits. The taskforce concluded its work by publishing an implementation plan in August 2023, which sets out a series of actions that have either been delivered, or will be delivered, over the coming months.</p><p>Local systems are best placed to consider how to utilise insourcing as part of their delivery plans, in a way which works for their areas. To support the system, NHS England produced <em>Guidance for trusts on the use of insourcing</em> and NHS Shared Business Services produced the <em>Insourcing of Clinical Services Framework Agreement</em>.</p>
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1699228

	human indexable
	published
	registered interest
	answer date	11/04/2024
	date	26/03/2024
	date tabled	26/03/2024
	ddp created	26/03/2024 21:36:48
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/03/2024 21:45:30 08/04/2024 11:59:52
	hansard heading	Cancer: Research
	house id	2
	identifier	HL3618
	legislature	25277
	parliament number	58
	question first answered	08/04/2024 11:25:36
	question text	To ask His Majesty's Government whether they will establish targeted funding to prioritise and drive research investment into pancreatic cancer and the other less survivable cancers.
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3618
	type	WrittenParliamentaryQuestion
	uin	HL3618
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Research is crucial in the fight against cancer, which is why the Department invests £1 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121 million for 2022/23.</p><p>In terms of establishing targeted funding into pancreatic cancer, the NIHR funds research in response to proposals received from scientists rather than allocating funding to specific disease areas. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.</p><p>The Government, through the NIHR, is committed to improving research into pancreatic cancer and cancers with the poorest survival rates by funding high quality, timely research that leads to improved outcomes for patients and the public, and makes the health and social care system more efficient, effective, and safe. Research evidence is vital for improving treatments and outcomes for people, including those with pancreatic cancer and other less survivable cancers.</p><p>In 2023, the Government awarded £2 million to new interdisciplinary research teams tackling hard to treat cancers, via the Medical Research Council, which hosted a two-day cancer sandpit strategic funding opportunity, focused on technological innovation for understanding cancers with the poorest survival rates.</p><p>The NIHR has funded seven research projects for pancreatic cancer for the period 2019 to 2023, with a total committed spend of approximately £3.6 million. The NIHR also supports the delivery of pancreatic cancer research funded by those in the charity and public sectors. For example, since 2019, the NIHR Clinical Research Network has supported over 70 pancreatic cancer-related studies.</p><p>The NIHR continues to encourage and welcome applications for research into any aspect of human health, including pancreatic cancer. All applications are assessed for funding by peer review committees. The level of research spend in a particular area is driven by factors including the quality of the proposals and their scientific potential. All applications for research into pancreatic cancer and other less survivable cancers made through open competition have been funded.</p>
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1699229

	human indexable
	published
	registered interest
	answer date	11/04/2024
	date	26/03/2024
	date tabled	26/03/2024
	ddp created	26/03/2024 21:36:49
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/03/2024 21:45:33 08/04/2024 11:59:51
	hansard heading	Cancer: Research
	house id	2
	identifier	HL3619
	legislature	25277
	parliament number	58
	question first answered	08/04/2024 11:25:36
	question text	To ask His Majesty's Government whether they will encourage the National Institute for Health and Care Research to rigorously evaluate existing research efforts and review how they can further prioritise and drive research investment for pancreatic cancer and other less survivable cancers.
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3619
	type	WrittenParliamentaryQuestion
	uin	HL3619
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Research is crucial in the fight against cancer, which is why the Department invests £1 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121 million for 2022/23.</p><p>In terms of establishing targeted funding into pancreatic cancer, the NIHR funds research in response to proposals received from scientists rather than allocating funding to specific disease areas. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.</p><p>The Government, through the NIHR, is committed to improving research into pancreatic cancer and cancers with the poorest survival rates by funding high quality, timely research that leads to improved outcomes for patients and the public, and makes the health and social care system more efficient, effective, and safe. Research evidence is vital for improving treatments and outcomes for people, including those with pancreatic cancer and other less survivable cancers.</p><p>In 2023, the Government awarded £2 million to new interdisciplinary research teams tackling hard to treat cancers, via the Medical Research Council, which hosted a two-day cancer sandpit strategic funding opportunity, focused on technological innovation for understanding cancers with the poorest survival rates.</p><p>The NIHR has funded seven research projects for pancreatic cancer for the period 2019 to 2023, with a total committed spend of approximately £3.6 million. The NIHR also supports the delivery of pancreatic cancer research funded by those in the charity and public sectors. For example, since 2019, the NIHR Clinical Research Network has supported over 70 pancreatic cancer-related studies.</p><p>The NIHR continues to encourage and welcome applications for research into any aspect of human health, including pancreatic cancer. All applications are assessed for funding by peer review committees. The level of research spend in a particular area is driven by factors including the quality of the proposals and their scientific potential. All applications for research into pancreatic cancer and other less survivable cancers made through open competition have been funded.</p>
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1699230

	human indexable
	published
	registered interest
	answer date	11/04/2024
	date	26/03/2024
	date tabled	26/03/2024
	ddp created	26/03/2024 21:36:51
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/03/2024 21:45:36 11/04/2024 11:28:05
	hansard heading	Health Services
	house id	2
	identifier	HL3620
	legislature	25277
	parliament number	58
	question first answered	11/04/2024 10:53:56
	question text	To ask His Majesty's Government when the major conditions strategy will be published.
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3620
	type	WrittenParliamentaryQuestion
	uin	HL3620
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Our intention is to publish the Major Conditions Strategy in the summer of this year.</p>
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1699231

	human indexable
	published
	registered interest
	answer date	11/04/2024
	date	26/03/2024
	date tabled	26/03/2024
	ddp created	26/03/2024 21:36:53
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/03/2024 21:45:39 08/04/2024 11:57:09
	hansard heading	NHS England: Data Protection
	house id	2
	identifier	HL3621
	legislature	25277
	parliament number	58
	question first answered	08/04/2024 11:26:03
	question text	To ask His Majesty's Government what deficiency in NHS England’s Secure Data Environment was described in paragraph 5.1.10 of the minutes from the 29 February meeting of the Advisory Group for Data, and what steps are being taken to rectify that deficiency.
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3621
	type	WrittenParliamentaryQuestion
	uin	HL3621
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The point made in the meeting was unrelated to any deficiency within the Secure Data Environment (SDE). The requirement from the Home Office is for specific statistical models and systems to be applied across the dataset requested, which is made up of aggregated data. This specific functionality is available from within the Home Office’s own technical environment, and not from within the SDE. There are no plans at this time to migrate this functionality within the SDE.</p>
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath